Fingerprint
Dive into the research topics of 'A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adults'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically